関連する実験動画
Updated: Jul 16, 2026

14:18
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
Published on: May 27, 2014
アブランヴィラミドとステファシジンスのエナチオセレクティブ全合成
Phil S Baran1, Benjamin D Hafensteiner, Narendra B Ambhaikar
1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. pbaran@scripps.edu
Journal of the American Chemical Society
|June 29, 2006
まとめ
この研究は,アヴランヴィラミドとステファシジン,複雑な抗がん天然剤の全合成を紹介しています. インドリックエナミドを合成するための新しい方法と,成功する酸化C-C結合形成戦略が開発され,ステファシジンAおよびB類の合成が可能になりました.
科学分野:
- 有機化学 オーガニック・ケミストリー
- 自然製品合成 自然製品の合成
- 薬用化学 薬用化学について
背景:
- アヴランビラミドとステファシジンは,抗がん性を持つ複雑な天然製品です.
- これまでの合成の取り組みは,範囲と効率が限られていた.
- 特徴的なビサイクロ[2.2.2]ディアゾオクタンコアは,重要な合成課題を提示しています.
研究 の 目的:
- アヴランビラミドとステファシジン の全合成を達成するために.
- 重要な構造モチーフの構築のための新しい合成方法論を開発する.
- 抗がん活動のための新しいアナログを準備し,評価する.
主な方法:
- コア構造のための正式なダイエルス・アルダーとビニール・ラジカル経路の探索.
- トリプトファン誘導体の直接脱水化のための新しい方法の開発.
- エステルとアミドカルボニル種のヘテロカップリングによる酸化C-C結合形成の応用.
主要な成果:
- ステファシジンAのエナンチオセレクティブ・トータル合成が成功し,その後アヴランビラミド経由でステファシジンBに変換された.
- インドリックエナミドを合成するための一般的な方法の開発.
- 新しく,ステレオ制御された酸化C-C結合形成戦略の実証.
結論:
- 開発された合成戦略は,アヴランビラミドとステファシジンへの効率的なアクセスを提供します.
- 新しい方法論は,他の生物活性天然製品の合成に適用できます.
- 合成されたアナログは,抗がん薬の開発の可能性を示しています.
関連する概念動画
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Sulfur Assimilation
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

